RIVASTIGMINE 13.3 MG/24HR PTCH

Rivastigmine
$1.9469per EA

Strength

13.3 mg/24h

Manufacturer

NorthStar Rx LLC

NDC

16714011702

Classification

Generic

Dosage Form

PATCH, EXTENDED RELEASE

Route

TRANSDERMAL

Last Updated

4/22/2026

Active Ingredients

RIVASTIGMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA206318

On Market Since

10/1/2019

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price History

1W

0.0%

1M

-5.6%

3M

-0.7%

6M

+0.8%

1Y

-2.7%

3Y

-19.2%

5Y

-51.1%

All

-45.5%